25-26 April, 2019

London, UK

Built for for strategic precision medicine, therapeutic area heads and diagnostic leaders, World CDx will tackle head on the new IVD regulations, providing insight on building utility evidence in the clinical trial and post-market setting, ensuring your diagnostic partner is ready for enforcement cut offs and revamping your commercial and reimbursement strategy to safeguard the successful launch and adoption of your diagnostic-enabled therapeutic.

Here to help strategic heads and commercial leads, the World CDx stream will tackle challenges along the development and commercial continuum to ensure the application of a diagnostic strategy ultimately maximises the market penetrate and market share of your precision medicines.

Key Topics to be Addressed in 2018:

symbol logo Understand the impact of the European IVDR on targeted therapeutic development, drug-Dx launch and real-world adoption and uptake of precision medicines
 symbol logo Refine your drug and Dx reimbursement strategy, gaining clarity on the payer perspective and the harnessing of RWE and health economics, to accelerate uptake of your precision medicine
 symbol logo Evaluate the real-world adoption and uptake of Dx testing to inform future platform selection to maximise market share of your precision medicines
symbol logo Evolve your European market access strategy to ensure successful commercialization, adoption and acquisition of market share for your drug-Dx product
 symbol logo Debate the new model for Rx-Dx partnering as we transition into a new Europe to ensure you adapt to a changing paradigm for clinical co-development and European-wide launch

9004 World CDx 270x60 Download Brochure Button